Apollomics, Inc. Receives China Investigational New Drug Approval for APL-102 to Initiate a Phase 1 Study Life Science
Healthcare Roundup – AstraZeneca teams up with CCT to conduct COVID-19 vaccine trials in Arizona; CureVac COVID-19 vaccine candidate stable at cool temp Life Science
Healthcare Roundup – AstraZeneca’s Calquence flunks mid-stage COVID-19 study; Biocept +4% on COVID-19 testing update Life Science
Healthcare Roundup – Sorrento files IND for antibody nasal spray for COVID-19; EU next to reach deal for Pfizer, BioNTech vaccine Life Science
Healthcare Roundup – Aurora Cannabis under pressure on proposed public offering, Canada OKs Becton, Dickinson rapid COVID-19 test Life Science
Healthcare Roundup – Futures add to big gains on vaccine hopes after Pfizer interim data, China vaccine trial suspended after ‘severe adverse event’ Life Science
Healthcare Roundup – Healthcare rallies as Presidential vote count continues, Novavax inks pact with Australia Life Science
Healthcare Roundup – Canopy Growth switches listing to Nasdaq, Brazil on board with resumption of J&J COVID-19 vaccine study Life Science
CEPI Extends Partnership With Clover Biopharmaceuticals to Fund COVID-19 Vaccine Candidate Through Global Phase 2/3 Study to Licensure Life Science
Nov. 5, 2020 – Diversified Investing Strategies Agenda Live – Life Science, Fintech, Clean Tech Sectors Covered! Cannabis, Energy, Life Science, Technology
Healthcare Roundup – CytoDyn to file marketing application for leronlimab, Takeda submits supplemental application for Cabometyx Life Science
Developing New Treatments with a Proprietary Cell-Based Therapy Platform | Lineage Cell Therapeutics, Inc. (NYSE American: LCTX) Life Science
Healthcare Roundup – Lilly ends COVID-19 antibody trial, Moderna inks COVID-19 vaccine supply deal in Qatar Life Science
